Related Experiment Video
Updated: Apr 16, 2026
10:11
Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
Published on: January 3, 2013
23.7K
Association between B7-H1 expression and bladder cancer: a meta-analysis
Y U Wang1, A N G Liu2, S H A N Zhao3
1Development Planning and Discipline Construction Office, China Medical University, Shenyang, Liaoning, China cmu_wy@126.com.
Genetics and Molecular Research : GMR
|March 3, 2015
Summary
Programmed death-L1 (B7-H1) expression is linked to increased bladder cancer risk and advanced clinical stage. This immune checkpoint molecule shows potential as a biomarker for bladder cancer progression.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- B7 homolog 1 (B7-H1), also known as programmed death-L1, is a key immune regulator in the B7/CD28 superfamily.
- B7-H1 exhibits differential expression across human and murine cell types, including constitutive low levels in dendritic cells and activated T cells, and high expression in monocytes and tumor cells.
Purpose of the Study:
- To investigate the association between B7-H1 expression and the risk of developing bladder cancer.
- To explore the correlation between B7-H1 expression and clinical parameters of bladder cancer.
Main Methods:
- A meta-analysis was performed to synthesize data from relevant studies.
- The analysis included a total of 352 bladder cancer cases and 60 healthy controls.
Main Results:
- Meta-analysis revealed a positive association between B7-H1 expression and bladder cancer.
- B7-H1 expression was strongly correlated with the clinical stage of bladder cancer.
- No significant associations were found between B7-H1 expression and gender or pathological grade.
Conclusions:
- B7-H1 expression is a potential indicator for bladder cancer risk and progression.
- Further research may elucidate B7-H1's role in bladder cancer pathogenesis and its utility as a biomarker.
